Optical Coherence Tomography Imaging in Systemic Sclerosis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

July 19, 2023

Conditions
Systemic SclerosisEarly Systemic Sclerosis Without Clinical Scleroderma and Onset < 2 Years
Interventions
DIAGNOSTIC_TEST

Non-invasive skin imaging assessment

"Intervention Description : (Limit: 1000 characters) Do not repeat information already included in arm/group descriptions. Specify details not covered in associated Arm~One session of Non-invasive skin imaging assessment contained:~* an examination on LC-OCT~* an examination on LC-OCT-doppler~* a fluid silicone molding~* an examination on HD ultrasound~The measurements will be applied on 3 skin sites: the dorsal surface of the finger, the inner face and the outer surface of the forearm.~The imaging assessment lasts 30 minutes in a dimly lit room where the humidity and temperature are stable."

Trial Locations (1)

67000

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT04532151 - Optical Coherence Tomography Imaging in Systemic Sclerosis | Biotech Hunter | Biotech Hunter